{"id":2841,"date":"2017-01-27T01:01:45","date_gmt":"2017-01-27T01:01:45","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=20121"},"modified":"2017-01-27T01:01:45","modified_gmt":"2017-01-27T01:01:45","slug":"medical-marijuana-inc-ceo-dr-stuart-titus-talks-advances-medical-marijuana-industry-uptick-newswire","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/01\/27\/medical-marijuana-inc-ceo-dr-stuart-titus-talks-advances-medical-marijuana-industry-uptick-newswire\/","title":{"rendered":"Medical Marijuana, Inc. CEO Dr. Stuart Titus Talks Advances in the Medical Marijuana Industry with Uptick Newswire"},"content":{"rendered":"
Dr. Titus began the interview relaying recent accomplishments by Medical Marijuana, Inc. and our portfolio of investment companies. This included discussing the potential of HempMeds\u00ae Brasil, our local distribution branch in the country. HempMeds\u00ae Brasil recently signed a deal with Paragon HealthCare BR to increase opportunities for distribution of RSHO\u2122 and expand the brand\u2019s presence in Brazil.<\/p>\n
The interview then moved to recent legalization efforts for both recreational and medical use of cannabis and the implications these endeavours have for the industry. With the soaring popularity of cannabinoids here in the U.S. and worldwide, there is incredible opportunity for companies like Medical Marijuana, Inc. to be able to provide legal cannabinoids to the market. <\/span><\/p>\n Next, Dr. Titus moved on to providing updates on the recent achievements of Medical Marijuana, Inc.\u2019s investment companies, including new products being added to the HempMeds\u00ae Brasil store, the upcoming one year anniversary of HempMeds\u00ae Mexico, and clinical trials on AXIM\u00ae Biotechnologies\u2019 CanChew\u00ae Plus CBD chewing gum for the treatment of irritable bowel syndrome (IBS), among others developments among our companies. <\/span><\/p>\n